Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. Summary
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
51400 52900 52100 51700 54800 Last
353923 449317 371456 271920 941115 Volume
-0.96% +2.92% -1.51% -0.77% +6.00% Change
Estimated financial data (e)
Sales 2021 1 221 B 1,04 B 1,04 B
Net income 2021 471 B 0,40 B 0,40 B
Net cash position 2021 548 B 0,46 B 0,46 B
P/E ratio 2021 6,08x
Yield 2021 6,85%
Sales 2022 758 B 0,64 B 0,64 B
Net income 2022 208 B 0,18 B 0,18 B
Net cash position 2022 724 B 0,61 B 0,61 B
P/E ratio 2022 13,8x
Yield 2022 1,37%
Capitalization 2 838 B 2 409 M 2 410 M
EV / Sales 2021 1,88x
EV / Sales 2022 2,79x
Nbr of Employees 833
Free-Float 67,9%
More Financials
Company
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP)... 
More about the company
Ratings of Seegene, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about SEEGENE, INC.
09/28Seegene, Inc.'s Equity Buyback announced on March 9, 2021, has expired.
CI
09/27SEEGENE : Unveils Fully Automated Molecular Testing System at the 2021 AACC
AQ
09/27Seegene Inc. Unveils Fully Automated Molecular Testing System At the 2021 AACC
CI
09/01SEEGENE : Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four C..
AQ
08/18SEEGENE : Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY
AQ
08/18Seegene Inc. Reports Earnings Results for the Second Quarter and First Half Ended June ..
CI
07/13SEEGENE : Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Vari..
AQ
07/13Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Var..
CI
07/06SEEGENE : announces partnership with Bio-Rad to develop diagnostic testing products for th..
AQ
07/02Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 9, 2021.
CI
07/02Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 9, 2021.
CI
06/29SEEGENE : unveils "MOBILE STATION," for on-site routine testing at public-use facilities a..
AQ
06/29Seegene Inc. Introduces its New Deployable Container Laboratory "Mobile Station", at th..
CI
05/25SEEGENE : reports solid results in the first quarter of 2021 with KRW 351.8 billion
AQ
05/23SEEGENE : introduces an exclusive diagnostic system for diagnosing COVID-19 variants at EC..
AQ
More news
News in other languages on SEEGENE, INC.
02/12++ Analysen des Tages von Dow Jones Newswires (12.02.2021) +++
02/12SEEGENE : ANALYSE/Südkoreas Gewinnabschöpfungsidee als internationales Vorbild?
More news
Chart SEEGENE, INC.
Duration : Period :
Seegene, Inc. Technical Analysis Chart | A096530 | KR7096530001 | MarketScreener
Technical analysis trends SEEGENE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 54 800,00 KRW
Average target price 84 500,00 KRW
Spread / Average Target 54,2%
EPS Revisions
Managers and Directors
Jong-Yoon Chun Chief Executive Officer & Director
Jung-Yong Kim Director & Head-Finance
Hong-Il Yoon Independent Director
Chang-Se Lee Independent Director
Kyung-Jun Chun Director
Sector and Competitors
1st jan.Capi. (M$)
SEEGENE, INC.-43.21%2 409
EXACT SCIENCES CORPORATION-27.39%16 160
GUARDANT HEALTH, INC.-15.15%11 077
INVITAE CORPORATION-33.05%6 083
BGI GENOMICS CO., LTD.-33.43%5 494
ADAPTIVE BIOTECHNOLOGIES CORPORATION-43.11%4 735